ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,877Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 107

$415K Total Retail Price of All Prescriptions

Rank: 39 out of 107

234 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 234 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

9% of this provider’s 234 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,795 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 491 491 1 6
FUROSEMIDE 394 394 2 3
WARFARIN SODIUM 337 337 3 8
LEVOTHYROXINE SODIUM 307 307 4 1
PREDNISONE 255 247 5 39
CITALOPRAM HBR 217 217 6 9
IPRATROPIUM-ALBUTEROL 215 215 7 49
METOPROLOL TARTRATE 208 208 8 7
QUETIAPINE FUMARATE 195 195 9 31
NAMENDA 171 171 10 19
POTASSIUM CHLORIDE 151 151 11 18
POLYETHYLENE GLYCOL 3350 139 138 12 24
ALBUTEROL SULFATE 138 138 13 67
GABAPENTIN 138 137 13 11
CARBIDOPA-LEVODOPA 132 132 15 56
LEVOFLOXACIN 120 120 16 101
LAMOTRIGINE 106 78 17 86
LISINOPRIL 105 105 18 4
RISPERIDONE 99 97 19 26
MIRTAZAPINE 97 97 20 16
SERTRALINE HCL 97 97 20 12
SIMVASTATIN 96 96 22 2
METFORMIN HCL 94 94 23 13
METOPROLOL SUCCINATE 90 90 24 15
DONEPEZIL HCL 88 88 25 10
CEFTRIAXONE 88 88 25 246
MORPHINE SULFATE 83 83 S2 27 150
PANTOPRAZOLE SODIUM 83 83 27 28
CLOTRIMAZOLE-BETAMETHASONE 81 79 29 129
GENTAMICIN SULFATE 76 76 30 335
SEROQUEL 75 75 31 87
ATENOLOL 73 73 32 21
TRAZODONE HCL 72 72 33 22
HYDROCODONE-ACETAMINOPHEN 71 71 S3 34 20
AGGRENOX 67 67 35 179
NITROGLYCERIN PATCH 66 66 36 222
AMLODIPINE BESYLATE 64 64 37 5
COLCRYS 64 64 37 189
CEPHALEXIN 63 62 39 120
TAMSULOSIN HCL 63 61 39 27
RAMIPRIL 62 62 41 134
PRAVASTATIN SODIUM 61 61 42 32
LANTUS 59 59 43 34
CLOPIDOGREL 58 58 44 29
CHLORHEXIDINE GLUCONATE 56 50 45 183
EXELON 55 55 46 111
LIDOCAINE HCL 54 54 47 309
CEFPODOXIME PROXETIL 54 54 47 378
ESCITALOPRAM OXALATE 52 52 49 40
DIGOXIN 52 52 49 37
ABILIFY 51 51 51 66
ERYTHROMYCIN 50 50 52 253
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.